[P2-09]Preliminary study for visualization of ketoconazole in skin by MALDI mass spectrometry imaging in the in vitro skin permeability test
*Hiroki Hisasue1, Hiroaki Aikawa1,2, Hideyuki Watanabe3, Mikiko Ootsuka4, Tomoko Koshikawa4, Akihiko Kajiwara4, Kenji Tasaki4, Shin-ichiro Nitta2,5, Norifumi Sakai1, Tomoharu Osada5, Kodo Miura2, Takeshi Kanno3,6, Tsuyoshi Higchi1(1. Safety Assessment Department, Kumamoto Laboratories, Non-clinical Business Segment, Business Management Division, Mediford Corporation, 2. Bioanalytical Department, Clinical Trial Business Segment, Business Management Division, Mediford Corporation, 3. Pathology Department, Kumamoto Laboratories, Non-clinical Business Segment, Business Management Division, Mediford Corporation, 4. Drug Metabolism and Analysis Department, Kashima Laboratories, Non-clinical Business Segment, Business Management Division, Mediford Corporation, 5. Advanced Medical Business Development Department, Corporate Strategy Division, Mediford Corporation, 6. Pathology Department, Kashima Laboratories, Non-clinical Business Segment, Business Management Division, Mediford Corporation)
Keywords:
MALDI,mass spectrometry imaging,dermatology
Password required to view
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.
Password is required to view the abstract. Please enter a password to authenticate.
